Skip to content

Serratus Intercostal Plane Block Versus Port Infiltration in Laparoscopic Cholecystectomy

Analgesic Efficacy of Serratus Intercostal Plane Block Versus Port Infiltration in Laparoscopic Cholecystectomy: Randomised Clinical Trial

Status
Active, not recruiting
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT07193472
Enrollment
128
Registered
2025-09-25
Start date
2025-06-02
Completion date
2025-12-31
Last updated
2025-10-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Postoperative Pain

Brief summary

Most patients undergoing laparoscopic cholecystectomy (LC) experience moderate to severe pain in the first 24 hours after surgery. Port infiltration is the usual analgesic method while serratus-intercostal plane blockade (SIPB) has shown its efficacy in open cholecystectomy pain control. The aim of the present study was to compare the efficacy of both techniques in pain control. OBJECTIVE The prospective randomised study has the working hypothesis is based on evaluating whether serratus-intercostal block (modified BRILMA) is equal or superior to laparoscopic port infiltration (PI) in terms of quality of postoperative recovery and pain control. Secondary objectives of the study will be to assess the absence of adverse effects. MATERIAL AND METHODS the investigators present a low-intervention clinical trial. The sample will be composed of 128 patients divided into two groups according to the analgesic technique (serratus-intercostal and port infiltration), following a 1:1 randomisation, consecutively until the sample size is reached and fulfilling the following criteria: signature of informed consent, over 18 years of age, ASA I-III, undergoing laparoscopic cholecystectomy. Intraoperatively, patients will receive standard monitoring and induction. Analgesia will consist of a multimodal strategy (8 mg dexamethasone, 1 g paracetamol and 50 mg dexketoprofen pre-incisionally, intraoperative fentanyl on demand and the corresponding regional technique). In the postoperative period, the main variable to be evaluated in forms designed for this purpose will be the difference in pain assessed by means of an numeric rating scale (NRS scale) and the quality of recovery will be measured by means of the modified Postoperative Quality of Recovery Score (QoR-15 ) recovery scale (15 responses).

Detailed description

Background Postoperative pain remains a significant concern following laparoscopic cholecystectomy (LC), with most patients experiencing moderate to severe pain within the first 24 hours. Traditionally, port-site infiltration (PI) with local anesthetics is employed for analgesia. However, the serratus-intercostal plane block (SIPB), also known as the modified BRILMA block, has demonstrated efficacy in pain management for open cholecystectomy. Its role in LC remains to be clarified. Objective The primary objective of this prospective randomised study is to evaluate whether SIPB (modified BRILMA block) provides equivalent or superior postoperative analgesia and quality of recovery compared to port-site infiltration in patients undergoing LC. Secondary objective: To assess the incidence of adverse effects related to each analgesic technique. Methods This study is designed as a low-intervention, prospective, randomized clinical trial. A total of 128 adult patients (ASA I-III) scheduled for elective laparoscopic cholecystectomy will be randomly allocated (1:1) to receive either serratus-intercostal plane block or laparoscopic port infiltration for perioperative analgesia. Randomization will be performed consecutively until the target sample size is reached. Inclusion Criteria: Age ≥ 18 years ASA physical status I-III Informed consent provided Exclusion Criteria: (Coagulopaty, allergy to local anaesthetic, history of chronic pain) Intraoperative Management: All patients will receive standardized general anesthesia and multimodal analgesia comprising: 8 mg dexamethasone 1 g paracetamol 50 mg dexketoprofen (administered pre-incisionally) Fentanyl as needed during surgery Assigned regional analgesic technique (SIPB or PI) Postoperative Evaluation: Primary Outcome Measures: Pain intensity using the Numerical Rating Scale (NRS) at predefined intervals Quality of recovery assessed via the modified QoR-15 questionnaire Secondary Outcome Measure:Incidence of adverse events or complications related to the analgesic techniques SIPB group: receive The Serratus intercostal plane block as analgesic technique after induction. With the patient lying in supine position, the local anaesthetic is administered in the plane under Serratus muscle at the 8th rib level Infiltration group: in this group the surgeons administered local anaesthetic after inserting the trocar. Conclusion (anticipated) This trial aims to determine whether SIPB offers superior analgesic efficacy and recovery quality compared to standard port infiltration in LC, potentially informing improved postoperative pain protocols.

Interventions

PROCEDUREserratus intercostal plane block as analgesic technique

the SIPB will be applied after starting surgery and before general anaesthesia

Sponsors

Hospital del Rio Hortega
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SEQUENTIAL
Primary purpose
TREATMENT
Masking
NONE

Masking description

both groups are masked about the receiving analgesia

Eligibility

Sex/Gender
ALL
Age
18 Years to 85 Years
Healthy volunteers
No

Inclusion criteria

* ASA I-II-III * laparoscopic cholecystectomy

Exclusion criteria

* Alergy to used drugs

Design outcomes

Primary

MeasureTime frameDescription
efectiveness of analgesia (SIPB versus IP)one yearThe working hypothesis is based on evaluating whether serratus-intercostal block (modified BRILMA) is equal or superior to laparoscopic port infiltration (PI) in terms of quality of postoperative recovery (QoR15) and pain control (NRS) 0-10

Secondary

MeasureTime frameDescription
side efectsone yearassesment of side efects
Postoperative pain controlOne yearPain developed for patients after surgery first 24 h . nRS 0-10
Postoperative recoveryOne yearIntake, rest at night, walking…assessed with QoR15 0- 150

Countries

Spain

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026